Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA CLÍNICA, MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, v. 72, n. 2, p. 195-201, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00228-015-1970-4. Acesso em: 26 set. 2024.APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2016). Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, 72( 2), 195-201. doi:10.1007/s00228-015-1970-4NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 set. 26 ] Available from: https://doi.org/10.1007/s00228-015-1970-4Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 set. 26 ] Available from: https://doi.org/10.1007/s00228-015-1970-4